Patent · US Active

NADPH oxidase inhibitors and uses thereof

US11236053B2 · kind B2 · utility

0Cited by

4References

19Claims

0Family size

Assignees

Inventors

Osman Güner · Abdulrahman Khaleefah Street, US
Bernard Lassegue · Decatur, US
Kathy Griendling · Stone Mountain, US
Qian Xu · Shandong, CN
David Brown · Durham, US
J. Phillip Bowen · Hull, US
Amol Kulkarni · Silver Spring, US
E. Blake Watkins · Jackson, US

Key dates

Filing date	Jul 26, 2018
Grant date	Feb 1, 2022
Priority date	—
Expiry date	Jul 26, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D307/54
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

This disclosure relates to compounds and methods of treating or preventing a Nox related disease or condition comprising administering to a subject in need thereof a Nox inhibitor or pharmaceutical compositions comprising a Nox inhibitor disclosed herein, derivatives, or compounds disclosed herein optionally substituted with one or more substitutes including optional salt and prodrug forms. In certain embodiments, this disclosure relates to sulfonylurea compounds and uses reported herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.